DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
- 专利权人:
- 发明人:
- Herriot Tabuteau
- 申请号：
- US15982794
- 公开号：
- US20180264016A1
- 申请日:
- 2018.05.17
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- Osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions.
- 来源网站：
- 中国工程科技知识中心
